Ovarian germ cell tumor epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
(→Age) |
|||
| Line 6: | Line 6: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence=== | ===Incidence=== | ||
*The incidence/ | ===Mature teratoma=== | ||
*The incidence of mature/benign teratoma is between 1.2 to 14.2 cases per 100,000 individuals worldwide.<ref name="pmid3166898">{{cite journal |vauthors=Westhoff C, Pike M, Vessey M |title=Benign ovarian teratomas: a population-based case-control study |journal=Br. J. Cancer |volume=58 |issue=1 |pages=93–8 |date=July 1988 |pmid=3166898 |pmc=2246492 |doi= |url=}}</ref> | |||
*The germ cell tumors of the ovary | *The germ cell tumors of the ovary consist approximately one-fourth of ovarian neoplasms and a great majority of them are benign. | ||
===Prevalence=== | ===Prevalence=== | ||
===Mature teratoma=== | ===Mature teratoma=== | ||
Revision as of 20:32, 25 February 2019
|
Ovarian germ cell tumor Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ovarian germ cell tumor epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Ovarian germ cell tumor epidemiology and demographics |
|
FDA on Ovarian germ cell tumor epidemiology and demographics |
|
CDC on Ovarian germ cell tumor epidemiology and demographics |
|
Ovarian germ cell tumor epidemiology and demographics in the news |
|
Blogs on Ovarian germ cell tumor epidemiology and demographics |
|
Risk calculators and risk factors for Ovarian germ cell tumor epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief:
Overview
Epidemiology and Demographics
Incidence
Mature teratoma
- The incidence of mature/benign teratoma is between 1.2 to 14.2 cases per 100,000 individuals worldwide.[1]
- The germ cell tumors of the ovary consist approximately one-fourth of ovarian neoplasms and a great majority of them are benign.
Prevalence
Mature teratoma
- Mature teratoma is the most common ovarian germ cell tumor tumor and accounts for 95% of ovarian teratomas.[2]
- The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
- In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
- The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
Case-fatality rate/Mortality rate
- In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
- The case-fatality rate/mortality rate of [disease name] is approximately [number range].
Age
Mature teratoma
- Patients of all age groups may develop mature teratoma.
- The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
- [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
- [Chronic disease name] is usually first diagnosed among [age group].
- [Acute disease name] commonly affects [age group].
Race
- There is no racial predilection to [disease name].
- [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
Gender
- [Disease name] affects men and women equally.
- [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
Developed Countries
Developing Countries
References
- ↑ Westhoff C, Pike M, Vessey M (July 1988). "Benign ovarian teratomas: a population-based case-control study". Br. J. Cancer. 58 (1): 93–8. PMC 2246492. PMID 3166898.
- ↑ Ulbright, Thomas M (2005). "Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues". Modern Pathology. 18: S61–S79. doi:10.1038/modpathol.3800310. ISSN 0893-3952.